• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Auro Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4899.0
  • ISIN : INE292C01011
247.55 -3 (-1.08%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    244.35

  • Today’s High

    253.00

  • Open

    248.90

  • Perv Close

    250.25

  • 52W Low

    156.40

  • 52W High

    307.20

Key Indicators

  • P/E(TTM)

    44.28

  • Mar.Cap (₹Cr.)

    154.22

  • Div & Yield %

    0.00

  • Book Value(₹)

    69.61

  • Debt-Equity Ratio

    -1.08

  • AGM Date

    30-Apr-2025

  • EPS

    5.59

  • P/E Ratio

    44.28

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    154.22

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.23

  • BV (₹)

    69.60

  • Sales( ₹ in Cr.)

    53.64

  • NP (in Cr.)

    7.79

  • NP Var(%)

    219.0

  • Div%

    0.0

  • CPS (₹)

    14.30

  • EPS (₹)

    12.50

  • Traded Value (₹ in Lakhs)

    155.91

  • 52 Week High

    307.20

  • 52 Week Low

    156.40

  • Price BSE

    250.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    155.91

  • P/C Ratio

    17.50

  • P/E Ratio

    20.00

  • Price Vs.BV

    12.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 53.64 52.89 50.87 54.25 43.79 46.82
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 53.64 52.89 50.87 54.25 43.79 46.82
Other Income 1.50 0.94 1.09 0.76 0.97 0.96
Stock Adjustments 2.48 1.61 0.98 -0.91 -0.49 1.77
Total Income 57.62 55.44 52.94 54.10 44.27 49.55
EXPENDITURE :            
Raw Materials 29.04 37.30 33.76 27.64 23.99 30.39
Power and Fuel Cost 2.43 2.08 1.67 1.60 1.69 1.64
Employee Cost 3.91 3.76 3.70 3.64 3.48 2.87
Other Manufacturing Expenses 1.16 1.42 1.76 2.10 1.61 1.36
Selling and Administration Expenses 7.31 4.73 5.86 5.84 5.03 4.18
Miscellaneous Expenses 1.60 0.82 0.48 1.29 1.23 1.16
Employee Benefit Expenses 3.91 3.76 3.70 3.64 3.48 2.87
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 45.45 50.11 47.22 42.10 37.03 41.60
Operating Profit 12.18 5.33 5.72 12.00 7.25 7.95
Interest 0.74 0.81 0.83 0.46 0.58 0.87
Gross Profit 11.44 4.52 4.89 11.54 6.67 7.08
Depreciation 1.09 1.07 1.02 1.04 1.02 1.01
Profit Before Tax 10.35 3.45 3.87 10.50 5.65 6.07
Current Tax 2.74 1.00 1.07 3.20 1.52 1.62
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.19 0.00 -0.04 0.12 0.06 0.05
Reported Net Profit 7.79 2.44 2.84 7.18 4.05 4.40
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 7.79 2.44 2.84 7.18 4.05 4.40
Adjustment below Net Profit -0.03 0.24 0.09 -0.09 0.03 0.03
P & L Balance brought forward 27.30 24.62 21.68 14.60 10.51 6.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 35.06 27.30 24.62 21.68 14.60 10.51
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 12.50 3.92 4.56 11.52 6.51 7.06
Earnings Per Share(Adj)-Unit Curr 12.50 3.92 4.56 11.52 6.51 7.06
Book Value 67.32 54.87 50.58 45.86 34.49 27.94
Book Value(Adj)-Unit Curr 67.32 54.87 50.58 45.86 34.49 27.94

Shareholding Pattern

  • Promoter Group

    52.18%

  • Public Share Holding

    47.82%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,168,781 18.75 1,168,781 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,083,126 33.42 2,083,126 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,251,907 52.18 3,251,907 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 400 0.01 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 400 0.01 0 1
2] Non Institution
Bodies Corporate 73,280 1.18 60,780 27
Clearing Members 10,217 0.16 10,217 8
Directors of their Relatives 10 0.00 10 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 389,807 6.25 238,607 226
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 66,631 1.07 66,131 84
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 379,281 6.09 379,281 8
Individuals holding nominal share capital up to Rs. 1 lakh 1,899,679 30.48 1,356,011 8,733
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 156,181 2.51 156,181 5
Sub Total 2,980,193 47.82 2,272,325 9,095
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,232,500 100.00 5,524,232 9,102

Company Background

Auro Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Auro Laboratories Ltd
  • BSE Code : 4899.0
  • ISIN : INE292C01011

  • Incorporation Year

    1989

  • Registered Office

    K-56 MIDC Indl Area
    Tarapur Boisar, Thane,
    Maharashtra-401506

  • Telephone

    91-22-66635456

  • FAX

  • Chairman

    Sharat Deorah

  • Managing Director

    Sharat Deorah

  • Company Secretary

    Priyanka Gupta

  • Auditor

    Kothari Jain & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Auro Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92